Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Janku Filip sold 41,845 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded Jun 23 to Jun 24, 2026 · Filed Jun 25, 2026
From Jun 23 to Jun 24, 2026, Janku Filip (Chief Medical Officer) sold 41,845 Monte Rosa Therapeutics, Inc. shares at an average US$21.08 for US$882K under a trading plan, leaving 59,992 shares. Filed Jun 25, 2026 (Form 4).
- Sold
- 41,845 shares
- Price
- US$21.08 average (US$20.22 to US$21.42)
- Value
- US$882K
- Holding after
- 59,992 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | Option exercise | 6,000 | US$7.56 | 71,837 | Direct |
| Jun 23, 2026 | Common Stock | Sale | 11,845 | US$20.22 | 59,992 | Direct |
| Jun 24, 2026 | Common Stock | Option exercise | 30,000 | US$7.56 | 89,992 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 30,000 | US$21.42 | 59,992 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Janku Filip
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Janku Filip · Jul 1, 2026
- Form 4 · Janku Filip · Jun 30, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026